Aurora Labs (A3D) AI Stock Analysis

• Market Cap: AU$15.19M
• Dividend Yield: N/A
• Average Volume (3M): 375.22K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.36
• Revenue Growth: 19.12%
• EPS Growth: 15.13%
• Country: AU
• Employees: 10
• Sector: Industrials
• Sector Strength: 78
• Industry: Industrial - Machinery
• EPS (TTM): >-0.01
• Shares Outstanding: 399,742,340
• 10 Day Avg. Volume: 331,704
• 30 Day Avg. Volume: 375,224
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

Aurora Labs Ltd. faces significant financial challenges with ongoing losses and weak cash flow, heavily impacting its overall score. Technical analysis suggests mild short-term support, but longer trends are negative. Valuation is problematic with a negative P/E ratio, indicating high risk. The absence of dividend yield adds to investor caution.

Aurora Labs Business Overview & Revenue Model

Company Description

Aurora Labs (A3D) is a technology company specializing in the development of 3D printing solutions, primarily targeting industrial applications. The company operates within the advanced manufacturing sector, providing innovative 3D printing hardware, software, and materials designed to enhance production efficiency and flexibility for various industries, including automotive, aerospace, and healthcare.

How the Company Makes Money

Aurora Labs generates revenue through the sale of its proprietary 3D printing machines and consumables, such as printing materials and components. Additionally, the company offers software solutions that facilitate the integration and optimization of 3D printing technology within existing manufacturing processes. Aurora Labs may also earn income through service contracts, providing maintenance and support for their hardware and software products. Strategic partnerships with key industry players can enhance their market reach and contribute to their earnings, although specific partnerships are not disclosed in the available data. The company might also explore licensing agreements for its technology to broaden its revenue base.

Aurora Labs Financial Statement Overview

Summary

Aurora Labs Ltd. is struggling financially with continuous losses, negative margins, and weak cash flow. Persistent operational inefficiencies and reliance on external financing present significant risks.

Income Statement

Aurora Labs Ltd. shows consistent revenue fluctuations with a recent minor increase from $134,564 to $174,296, marking a 29.5% growth. However, the company has been incurring significant losses with a consistent negative gross profit margin and a net profit margin of -1609.3% for 2024. Despite slight improvements, EBIT and EBITDA margins remain negative, indicating ongoing operational challenges.

Balance Sheet

The company's balance sheet reflects a weak equity position with a decreasing stockholders' equity over time. The debt-to-equity ratio is moderate at 0.47, showing some reliance on debt but not excessively high. However, the equity ratio of 57.9% is concerning given the company's ongoing losses.

Cash Flow

Aurora Labs Ltd. has a negative free cash flow, with a slight improvement in operating cash flow from -$2,571,694 to -$2,401,655. The free cash flow to net income ratio remains negative, reflecting insufficient cash generation to cover operational losses. While financing cash flow is positive, it primarily covers deficits rather than growth initiatives.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	174.30K	134.56K	32.20K	171.62K	414.86K
Gross Profit	57.13K	58.81K	13.89K	-145.00K	173.02K
EBITDA	-3.23M	-3.37M	-3.70M	-4.81M	-8.90M
Net Income	-2.81M	-2.96M	-3.15M	-4.42M	-8.16M
Balance Sheet
Total Assets	3.08M	2.18M	3.35M	2.91M	5.04M
Cash, Cash Equivalents and Short-Term Investments	1.65M	986.80K	1.95M	1.37M	1.32M
Total Debt	842.94K	65.39K	160.53K	252.00K	993.40K
Total Liabilities	1.30M	719.35K	716.58K	711.20K	1.65M
Stockholders Equity	1.78M	1.46M	2.63M	2.20M	3.39M
Cash Flow
Free Cash Flow	-2.41M	-2.60M	-2.68M	-1.68M	-6.88M
Operating Cash Flow	-2.40M	-2.57M	-2.63M	-1.68M	-6.29M
Investing Cash Flow	-7.69K	-23.07K	-48.42K	6.86K	-594.61K
Financing Cash Flow	3.07M	1.63M	3.25M	1.72M	4.61M

Aurora Labs Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Neutral. The current price of 0.04 is above the 20-day moving average (MA) of 0.04, above the 50-day MA of 0.04, and below the 200-day MA of 0.06, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.59 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:A3D.

Aurora Labs Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VBC	76 Outperform	€27.76M	10.11	14.71%	―	-17.71%	―
SSH	67 Neutral	AU$11.51M	11.90	9.53%	―	11.60%	―
EMB	64 Neutral	AU$17.59M	12.90	6.82%	4.29%	-20.98%	18.62%
Sector *	59 Neutral	AU$1.63B	11.13	-5.90%	3.58%	9.76%	6.86%
AL3	51 Neutral	AU$171.97M	―	-20.13%	―	421.43%	62.31%
3DA	49 Neutral	AU$370.82M	―	-68.99%	―	376.05%	-15.52%
A3D	46 Neutral	AU$15.19M	―	-263.00%	―	19.12%	15.13%

Aurora Labs Corporate Events

Aurora Labs Announces Director Change: Terry Stinson Departs

Aurora Labs Limited has announced the cessation of Terry Stinson as a director, effective July 30, 2025. The notice details Stinson’s holdings, including 837,974 ordinary shares and various unlisted options. This change in directorship may influence the company’s strategic direction and stakeholder interests, reflecting a potential shift in leadership dynamics.

Aurora Labs Advances Micro Gas Turbine Program with Key Developments

Aurora Labs has made significant strides in its micro gas turbine program, entering a critical pre-durability testing phase for its AU2 and AU4 engines. The company has upgraded its test bench infrastructure to support high-frequency data capture, essential for meeting military standards and optimizing engine performance. Additionally, Aurora Labs secured a $544,333 Defense Industry Development Grant to scale up production of its propulsion systems, with facility upgrades underway to enhance manufacturing capabilities. The company is also preparing to exhibit its turbines at DSEI 2025 in London, which will provide international exposure. These developments mark a significant step towards the production of affordable, 3D-printed propulsion systems for defense applications, potentially strengthening Aurora Labs’ position in the defense industry.

Aurora Labs Secures Defence Grant to Boost Production

Aurora Labs Limited has been awarded a $544,333 Defence Industry Development Grant under the Sovereign Industrial Priorities Stream to enhance its production capabilities for gas turbine propulsion systems. This funding will support the acquisition of advanced manufacturing equipment, enabling the company to scale production for defence aerospace and maritime applications at its Canning Vale facility. The grant will assist Aurora in vertically integrating its production processes onshore, reducing reliance on foreign supply chains, and strengthening Australia’s defence capabilities. This development positions Aurora to meet growing demand for its propulsion systems in the defence sector, supporting the country’s strategic autonomy.

Aurora Labs Enters U.S. Aerospace Market with Mayman Aerospace Partnership

Aurora Labs has signed a Memorandum of Understanding with Mayman Aerospace to explore the development of 3D-printed micro gas turbines and propulsion systems for VTOL aircraft. This strategic partnership marks Aurora Labs’ entry into the U.S. aerospace market, offering opportunities to validate its technologies and enhance its position in propulsion innovation. The collaboration is expected to accelerate the commercialization of 3D printed propulsion systems and increase Aurora Labs’ visibility among key U.S. aerospace stakeholders.

Aurora Labs Secures $500,000 Loan for R&D Commercialization

Aurora Labs Limited has secured a $500,000 loan against its 2025 Research and Development tax credit, with an interest rate of 15% per annum over a four-month term. The funds will be used primarily for technology commercialization, including production plant and equipment for propulsion systems products, and working capital, which may enhance the company’s operational capabilities and market positioning.

Aurora Labs Advances 3D-Printed Propulsion System for Australian Defence

Aurora Labs Ltd has achieved a significant milestone in its contract with the Australian Defence Force by completing the design freeze phase for a novel 3D-printed propulsion system. This development marks a strategic advancement in the company’s capabilities, aligning with Australia’s defense initiatives to enhance domestic manufacturing and technological innovation. The successful completion of this phase underscores Aurora Labs’ technical prowess and commitment to developing sovereign production capabilities, which are crucial for supporting the Australian Defence Force’s strategic objectives.

Aurora Labs Announces Cessation of 720,000 Securities

Aurora Labs Limited has announced the cessation of 720,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of May 2, 2025. This development may impact the company’s capital structure and could have implications for its market positioning and stakeholders.